Mature B-cell Malignancies
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB08935 | Obinutuzumab | 1 | Recruiting | 1 |
| DB15035 | Zanubrutinib | 1 | Recruiting | 1 |
| DB15035 | Zanubrutinib | 1 / 2 | Active Not Recruiting | 1 |
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB08935 | Obinutuzumab | 1 | Recruiting | 1 |
| DB15035 | Zanubrutinib | 1 | Recruiting | 1 |
| DB15035 | Zanubrutinib | 1 / 2 | Active Not Recruiting | 1 |